• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NBS1 8360G>C 多态性与乳腺癌风险相关:一项荟萃分析。

NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.

机构信息

Department of Epidemiology and Biostatistics, Nanjing Medical University, 210029, Nanjing, China.

出版信息

Breast Cancer Res Treat. 2010 Sep;123(2):557-61. doi: 10.1007/s10549-010-0772-8. Epub 2010 Feb 9.

DOI:10.1007/s10549-010-0772-8
PMID:20143155
Abstract

NBS1 gene plays an important role in DNA repair. Many epidemiological studies have investigated the association between NBS1 8360G > C polymorphism and breast cancer, however, the results are still controversial. Therefore, we performed a meta-analysis of 10 case-control studies. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. The results showed NBS1 8360G > C polymorphism contributed to breast risk in overall populations (for CC vs. GG: OR = 0.75, 95% CI = 0.74-0.98, P = 0.13 for heterogeneity; for the recessive model CC vs. GG/CG: OR = 0.88, 95% CI = 0.77-1.00, P = 0.44 for heterogeneity). In subgroup analysis by ethnicity, no significant association was found in all genetic models. In summary, our meta-analysis strongly suggests the NBS1 8360G > C polymorphism is associated with breast cancer.

摘要

NBS1 基因在 DNA 修复中发挥重要作用。许多流行病学研究已经调查了 NBS1 8360G>C 多态性与乳腺癌之间的关联,但结果仍存在争议。因此,我们对 10 项病例对照研究进行了荟萃分析。使用粗比值比(ORs)及其 95%置信区间(CIs)来评估关联的强度。结果表明,NBS1 8360G>C 多态性与总体人群的乳腺癌风险有关(对于 CC 与 GG:OR=0.75,95%CI=0.74-0.98,P=0.13 用于异质性;对于隐性模型 CC 与 GG/CG:OR=0.88,95%CI=0.77-1.00,P=0.44 用于异质性)。按种族亚组分析,所有遗传模型均未发现显著相关性。总之,我们的荟萃分析强烈表明 NBS1 8360G>C 多态性与乳腺癌相关。

相似文献

1
NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.NBS1 8360G>C 多态性与乳腺癌风险相关:一项荟萃分析。
Breast Cancer Res Treat. 2010 Sep;123(2):557-61. doi: 10.1007/s10549-010-0772-8. Epub 2010 Feb 9.
2
MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.亚甲基四氢叶酸还原酶 C677T 多态性与乳腺癌易感性相关:一项包含 15260 例病例和 20411 例对照的荟萃分析。
Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.
3
Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.亚甲基四氢叶酸还原酶多态性与乳腺癌风险:来自 41 项研究的荟萃分析,包括 16480 例病例和 22388 例对照。
Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.
4
RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.RAD51 135G>C 多态性与乳腺癌易感性相关:一项包含 26444 例个体的荟萃分析。
Breast Cancer Res Treat. 2010 Dec;124(3):765-9. doi: 10.1007/s10549-010-0885-0. Epub 2010 Apr 16.
5
TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.TGFB1 L10P 多态性与乳腺癌易感性相关:一项包含 47817 例个体的荟萃分析证据。
Breast Cancer Res Treat. 2010 Sep;123(2):563-7. doi: 10.1007/s10549-010-0781-7. Epub 2010 Feb 9.
6
Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.白细胞介素 6 基因启动子中的功能性多态性与乳腺癌风险之间缺乏关联:一项涉及 25703 例受试者的荟萃分析。
Breast Cancer Res Treat. 2010 Jul;122(2):483-8. doi: 10.1007/s10549-009-0706-5. Epub 2009 Dec 31.
7
Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.CYP1A2-164A/C 多态性与乳腺癌易感性缺乏关联:一项包含 17600 例个体的荟萃分析。
Breast Cancer Res Treat. 2010 Jul;122(2):521-5. doi: 10.1007/s10549-009-0731-4. Epub 2010 Jan 7.
8
Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.锰超氧化物歧化酶 Val16Ala 多态性与乳腺癌风险之间缺乏关联:一项涉及 58448 例受试者的荟萃分析。
Breast Cancer Res Treat. 2010 Sep;123(2):543-7. doi: 10.1007/s10549-010-0777-3. Epub 2010 Feb 9.
9
The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects.HSD17B1 Ser312Gly 多态性与乳腺癌风险的关联:一项包含 31053 例受试者的荟萃分析。
Breast Cancer Res Treat. 2010 Sep;123(2):577-80. doi: 10.1007/s10549-010-0784-4. Epub 2010 Feb 12.
10
TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.TGFB1 T29C 多态性与乳腺癌风险:基于 10417 例病例和 11455 例对照的荟萃分析。
Breast Cancer Res Treat. 2010 Oct;123(3):857-61. doi: 10.1007/s10549-010-0766-6. Epub 2010 Feb 16.

引用本文的文献

1
The Role of Alternative Splicing Factors, DDB2-Related Ageing and DNA Damage Repair in the Progression and Prognosis of Stomach Adenocarcinoma Patients.替代剪接因子、DDB2 相关的衰老和 DNA 损伤修复在胃腺癌患者进展和预后中的作用。
Genes (Basel). 2022 Dec 23;14(1):39. doi: 10.3390/genes14010039.
2
Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population.中国人群中泛素化FANCD2-DNA损伤修复通路基因单核苷酸多态性与乳腺癌的关联
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818819841. doi: 10.1177/1533033818819841.
3
Homologous Recombination Repair Polymorphisms and the Risk for Osteosarcoma.
同源重组修复多态性与骨肉瘤风险
J Med Biochem. 2015 Apr;34(2):200-206. doi: 10.2478/jomb-2014-0031. Epub 2015 Mar 3.
4
Association of the nibrin gene () variants with breast cancer.尼布林基因()变异与乳腺癌的关联。
Biomed Rep. 2016 Mar;4(3):369-373. doi: 10.3892/br.2016.579. Epub 2016 Jan 25.
5
DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.DNA修复系统与肾细胞癌预后:受NBS1影响
Med Oncol. 2015 Nov;32(11):255. doi: 10.1007/s12032-015-0701-0. Epub 2015 Oct 22.
6
Carriage of NBN polymorphisms and acute leukemia risk.NBN基因多态性与急性白血病风险的携带情况
Int J Clin Exp Med. 2015 Mar 15;8(3):3769-76. eCollection 2015.
7
Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.中国参与同源重组修复(HRR)途径基因的MRE11A、NBS1、RAD51和RAD52的微小RNA结合位点单核苷酸多态性与乳腺癌风险的评估
Mol Genet Genomics. 2015 Jun;290(3):1141-53. doi: 10.1007/s00438-014-0983-5. Epub 2015 Jan 9.
8
Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.癌症风险评估中的种族背景与基因变异:一项系统综述
PLoS One. 2014 Jun 5;9(6):e97522. doi: 10.1371/journal.pone.0097522. eCollection 2014.
9
NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.NBN 基因多态性与癌症易感性:系统评价。
Curr Genomics. 2013 Nov;14(7):425-40. doi: 10.2174/13892029113146660012.
10
Association between the NBS1 Glu185Gln polymorphism and lung cancer risk: a systemic review and meta-analysis.NBS1 Glu185Gln 多态性与肺癌风险的关联:系统评价和荟萃分析。
Mol Biol Rep. 2013 Mar;40(3):2711-5. doi: 10.1007/s11033-012-2358-5. Epub 2012 Dec 29.